← Back to Search

Mobile Cognitive Behavioral Therapy for Anxiety and Depression

N/A
Recruiting
Led By Patricia Marino
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up endpoint [week 6]
Awards & highlights

Study Summary

This trial aims to compare how effective CBT with a mobile app is compared to CBT alone for improving anxiety and depression.

Who is the study for?
This trial is for medical and graduate students aged 18-40 at Weill Cornell Medicine who are experiencing significant anxiety or depression, as indicated by specific scores on recognized scales. It's not open to those with a history of bipolar or psychotic disorders, or current severe suicidal intentions.Check my eligibility
What is being tested?
The study compares two approaches: standard clinician-delivered cognitive behavioral therapy (CBT) versus CBT with the addition of 'MAYA', a mobile app designed to support mental health. Participants will use MAYA twice weekly alongside regular CBT sessions and complete weekly self-assessments.See study design
What are the potential side effects?
While using the MAYA app isn't expected to have physical side effects, participants may experience emotional discomfort when confronting difficult thoughts or feelings during cognitive behavioral therapy exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~endpoint [week 6]
This trial's timeline: 3 weeks for screening, Varies for treatment, and endpoint [week 6] for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety symptoms from baseline to end of treatment as measured by the GAD-7.
Change in depressive symptoms from baseline to end of treatment as measured by the PHQ-9
Secondary outcome measures
Adherence as measured by the mean difference in total number of completed clinician assigned homework between groups
Retention as measured by the mean difference in total number of completed study weeks between groups

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Clinician-delivered CBT + Supplemental appExperimental Treatment2 Interventions
Mobile application at least two times per week for six weeks, for at least 20 minutes on each of the two days in addition to the clinician-delivered CBT
Group II: Clinician-delivered Cognitive Behavioral Therapy onlyActive Control1 Intervention
Participants receive treatment with a licensed clinician for 6 weeks.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,059 Previous Clinical Trials
1,316,043 Total Patients Enrolled
16 Trials studying Anxiety Disorders
881 Patients Enrolled for Anxiety Disorders
Patricia MarinoPrincipal InvestigatorWeill Medical College of Cornell University

Media Library

Clinician Delivered CBT Clinical Trial Eligibility Overview. Trial Name: NCT05823922 — N/A
Anxiety Disorders Research Study Groups: Clinician-delivered CBT + Supplemental app, Clinician-delivered Cognitive Behavioral Therapy only
Anxiety Disorders Clinical Trial 2023: Clinician Delivered CBT Highlights & Side Effects. Trial Name: NCT05823922 — N/A
Clinician Delivered CBT 2023 Treatment Timeline for Medical Study. Trial Name: NCT05823922 — N/A
Anxiety Disorders Patient Testimony for trial: Trial Name: NCT05823922 — N/A
~67 spots leftby Jun 2025